Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

2014433 citationsJournal Articlehybrid Open Access

Authors

Nicholas D. James · University of Warwick

Melissa Spears · Medical Research Council

Noel W. Clarke · The Christie NHS Foundation Trust

David P. Dearnaley · Institute of Cancer Research

Johann S. de Bono · Institute of Cancer Research

Joanna Gale · Queen Alexandra Hospital

John Hetherington

Abstract

Results from this control arm cohort found survival is relatively short and highly influenced by patient age, fitness, and where prostate cancer has spread in the body.

Topics & Keywords

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Cancer, Lipids, and Metabolism

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Urology

Volume 67, Issue 6, pp. 1028-1038

DOI: 10.1016/j.eururo.2014.09.032

Field-Weighted Citation Impact: 28.67